SMTL ID : 5o7i.1

ERK5 in complex with a pyrrole inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.38 Å

Oligo State

monomer

Ligands

1 x 9N8: 4-(2-bromanyl-6-fluoranyl-phenyl)carbonyl-~{N}-pyridin-3-yl-1~{H}-pyrrole-2-carboxamide(Non-covalent)

9N8.1: 15 residues within 4Å: Chain A: I.17, Y.22, V.25, A.38, K.40, I.71, L.93, D.94, L.95, M.96, E.97, N.143, L.145, G.155, D.156 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:I.17, A:L.93, A:L.145 Hydrogen bonds: A:D.94, A:M.96 Water bridges: A:D.156 pi-Stacking: A:Y.22

1 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)

DMS.2: 3 residues within 4Å: Chain A: L.110, T.111, R.214 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:R.214

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Myers, S.M. et al., Identification of a novel orally bioavailable ERK5 inhibitor with selectivity over p38 alpha and BRD4. Eur.J.Med.Chem. (2019)

Release Date

2018-06-20

Peptides

Mitogen-activated protein kinase 7: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Mitogen-activated protein kinase 7

Related Entries With Identical Sequence